FDA Recall Terminated

BD-Retic-Count Reticulocyte Reagent System; Hematology: Used for in vitro diagnostics

Recall: Z-1390-2016 · Initiated March 18, 2016

Recall

Recall Number
Z-1390-2016
Event Number
73597
Firm
Becton, Dickinson and Company, BD Biosciences
FEI Number
2916837
Product Code
GKL
Status
Terminated
Root Cause
Under Investigation by firm
Initiated
March 18, 2016
Terminated
December 2, 2016
Address
2350 Qume Dr, San Jose, CA, 95131-1812

Description

BD-Retic-Count Reticulocyte Reagent System; Hematology: Used for in vitro diagnostics

Reason

The carton label for one lot of BD Retic-Count Reticulocyte Reagent System had the incorrect storage conditions. The labels on the reagent as well as the Instructions for Use are correct.

Action

BD Biosciences sent an Urgent Product Recall letter on March 18, 2016, to all affected customers by certified mail. The letter identified the product the problem and the action needed to be taken by the customer. Customer Actions: 1. Examine your data files obtained using reagents from the affected lots for low performance. 2. Discard all remaining stock of BD Retic-Counter reticulocyte reagent system, Catalog Number 349204, lot number 5175559, and request replacement product. BD will replace product at no cost. 3. As a requirement of our Regulatory Tracking Process, we request that you complete the enclosed Tracking/Verification form , even if you no longer have the affected reagents listed in your inventory. Please return the Tracking/Verification form to BD Biosciences, per the instructions (mail, fax, or email). If you require further assistance, please contact BD Customer Support at 877.232.8995 (prompt 3, 3) in the United States. For customers outside the US, contact your local BD Biosciences representative or distributor.

Distribution

Worldwide Distribution - US Distribution to the states of : CT, MN, FL, NY, CA, MA, DC, UT, VA and IN., and to the countries of : Belgium, Brazil, Canada, China, India, Japan, Korea, Singapore and Taiwan.

Quantity

205